This inventor holds 1 USPTO granted patent. Top assignee: Selectx Pharmaceuticals, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Michael G. Chaparian: Innovator in Antibiotic Development
Introduction
Michael G. Chaparian is a notable inventor based in Washington Township, MI (US). He has made significant contributions to the field of antibiotic research, particularly in developing new compounds to combat bacterial infections.
Latest Patents
Chaparian holds a patent for "4,6-substituted 2,5-dideoxystreptamine aminoglycoside antibiotics." This innovative antibiotic formula is designed to treat bacterial infections, especially those resistant to existing antibiotics. His work in this area is crucial for advancing medical treatments and improving patient outcomes.
Career Highlights
Michael G. Chaparian is associated with Selectx Pharmaceuticals, Inc., where he applies his expertise in antibiotic development. His career reflects a commitment to addressing critical health challenges through innovative solutions.
Collaborations
Throughout his career, Chaparian has collaborated with talented professionals, including Michael Brady and Scott Moe. These partnerships have enhanced his research and contributed to the advancement of antibiotic therapies.
Conclusion
Michael G. Chaparian's work in antibiotic innovation exemplifies the importance of research in combating resistant bacterial infections. His contributions are vital to the ongoing efforts in the medical field to develop effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile